Year Established :
2015
Total Assets(USD) :
500,000 to 99,999,999
Total Number of Staff :
10-50
Main Competitive Advantages :
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages :
Our company is dedicated to research, production and sales of chiral phosphorus ligands, organophosphorus ligands and related functional intermediates and pharmaceutical intermediates. Basing on the features of our company and the demands of products, we have compiled the QC brochure and related procedure files to audit the QC system for all colleagues and the whole production procedure from lab research to commerical production. Matured research, technologies and high quality products can meet the quality demand of our customers.
As always, our company is dedicated to:
◆Insist on service innovation, pursue full satisfaction and excellent experience of our customers;
◆Insist on technology innovation, keep developing the quality of products and service.
Analysis instruments include NMR, GC-MS, LC-MS, KF, GC, HPLC, IR and Polarimeter, etc.
Business Type :
Manufacturer
R&D Capacity :
OEM,ODM,Own Brand
Annual Turnover(USD) :
500,000 to 99,999,999
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Asia
Product Range :
Research Direction Ⅰ: Design, synthesis and development of organophosphorus catalysts
◆Organophosphorus ligands: Development and application of organophosphorus ligands, including bidental phosphorus ligands, biphenyl phosphorus ligands, ferrocene phosphorus ligands and other chiral organophosphorus ligands
◆Homogeneous Catalyst: Development and application of organic precious metal homogeneous catalysts.
Research Direction Ⅱ: Design, synthesis and development of functional intermediates and pharmaceutical intermediates.
◆Design, synthesis and development of organosilicon and organoboron functional intermediates.
◆Design, synthesis and development of chiral pharmaceutical intermediates.
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
